Vitronectin: Back into the spotlight

Journal of Thrombosis and Haemostasis

Volumn 3, Issue 5, 2005, Pages 873-874

  Plow, E F ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMA PROTEIN; VITRONECTIN; VON WILLEBRAND FACTOR; FIBRINOGEN RECEPTOR; GLYCOPROTEIN; LIGAND; VITRONECTIN RECEPTOR;

BLOOD VESSEL OCCLUSION; DISEASE MODEL; GLANZMANN DISEASE; HEMOSTASIS; MICROSCOPY; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN BINDING; THROMBOGENESIS; ANIMAL; CHEMISTRY; GENETICS; HUMAN; METABOLISM; MOUSE; PHYSIOLOGY; THROMBOCYTE AGGREGATION; THROMBOSIS; TRANSGENIC MOUSE;

ANIMALS; GLYCOPROTEINS; HEMOSTASIS; HUMANS; LIGANDS; MICE; MICE, TRANSGENIC; PLATELET AGGREGATION; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PROTEIN BINDING; RECEPTORS, VITRONECTIN; THROMBOSIS; VITRONECTIN;

EID: 23844437703     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2005.01324.x     Document Type: Note

References (12)

1. Hynes RO, Hodivala-Dilke KM. Insights and questions arising from studies of a mouse model of Glanzmann thrombasthenia. Thromb Haemost 1999; 82: 481-5.
2. Quinn MJ, Byzova TV, Qin J, Topol EJ, Plow EF. Integrin αIIbβ3 and its antagonism. Arterioscler Thromb Vasc Biol 2003; 23: 945-52.
3. Ni H, Denis CV, Subbarao S, Degen JL, Sato TN, Hynes RO, Wagner DD. Persistence of platelet thrombus formation in arterioles of mice lacking both Willebrand factor and fibrinogen. J Clin Invest 2000; 106: 385-92.
4. Asch E, Podack ER. Vitronectin binds to activated platelets and plays a role in platelet aggregation. J Clin Invest 1990; 85: 1372-8.
5. Thiagarajan P, Kelley KL. Exposure of binding sites for vitronectin on platelets following stimulation. J Biol Chem 1988; 263: 3035-8.
6. Ruoslahti E. RGD and other recognition sequences for integrins. Annu Rev Cell Biol 1996; 12: 697-715.
7. Reheman A, Gross P, Yang H, Chen P, Allen D, Leytin V, Freedman J, Ni H. Vitronectin stabilizes thrombi and vessel occlusion but plays a dual role in platelet aggregation. J Thromb Haemost 2005; 3: 875-83.
8. Zheng X, Saunders TL, Camper SA, Samuelson LC, Ginsburg D. Vitronectin is not essential for normal mammalian development and fertility. Proc Natl Acad Sci USA 1995; 92: 12426-30.
9. Fay WP, Parker AC, Ansari MN, Zheng X, Ginsburg D. Vitronectin inhibits the thrombotic response to arterial injury in mice. Blood 1999; 93: 1825-30.
10. Seiffert D, Schleef RR. Two functionally distinct pools of vitronectin (Vn) in the blood circulation: identification of a heparin-binding competent population of Vn within platelet alpha-granules. Blood 1996; 88: 552-60.
11. Izumi M, Yamada KM, Hayashi M. Vitronectin exists in two structurally and functionally distinct forms in human plasma. Biochim Biophys Acta 1989; 990: 101-8.
12. Stockmann A, Hess S, Declerck P, Timpl R, Preissner KT. Multimeric vitronectin. Identification and characterization of conformation-dependent self-association of the adhesive protein. J Biol Chem 1993; 268: 22874-82.